Douglas Sborov, MD MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Janssen
    Topic:
    Advisory
    Date added:
    05/09/2022
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    GlaxoSmithKline
    Topic:
    Consulting
    Date added:
    05/09/2022
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Abbvie
    Topic:
    Consulting
    Date added:
    05/09/2022
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Topic:
    Consulting
    Date added:
    05/09/2022
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Bristol Myer Squibb
    Topic:
    Advisory
    Date added:
    05/09/2022
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Arcellx
    Topic:
    Advisory
    Date added:
    04/01/2023
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Consulting
    Date added:
    04/01/2023
    Date updated:
    04/29/2024
    Relationship end date:
    12/31/2023
Return to Montana Hematology Oncology Conference